-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation